
Blood Cancer Treatments: How Stem Cell Transplants and Immunotherapy Are Changing the Game
Do you know, every 3 minutes, someone is diagnosed with blood cancer, making it one of the most prevalent and life-threatening cancers worldwide? Traditional treatments like chemotherapy and radiation, though effective, often weaken the immune system and come with severe side effects. But now, stem cell transplants and immunotherapy are transforming survival chances.
Studies show that stem cell treatment for cancer improves survival rates by up to 60% in certain blood cancers, while immunotherapy has led to 90% remission rates in some leukaemia patients. These breakthroughs not only fight cancer but also reduce relapse risks. In this blog, we’ll explore how these cutting-edge treatments work and why they are reshaping the future of blood cancer treatment.
In this blog, we’ll explore how these cutting-edge treatments work and why they are reshaping the future of blood cancer treatment.
Understanding Blood Cancer
What Causes Blood Cancer?
Blood cancer is caused by abnormalities in the growth and function of white blood cells. In a healthy body, white blood cells are continuously produced to replace old and damaged ones. The uncontrolled production of white blood cells in the bone marrow leads to blood cancers. The abnormality in cells can be caused due to genetic mutations in blood-forming cells, often leading to uncontrolled cell growth.
Risk Factors of Blood Cancer
Blood cancer can be caused by several risk factors. These factors can be genetic, environmental, or immune-related, such as family history, genetic mutations, radiation and chemical exposure, autoimmune disorders, and immunosuppression. Understanding these risk factors can help with early detection, prevention, and better management of the disease.
Category | Risk Factor | Description |
I. Genetic & Biological | Family History
| The risk is increased if you have a close family member with leukaemia, lymphoma, or myeloma, such as a parent or brother. |
Genetic Mutations | DNA changes in blood-forming cells can trigger uncontrolled growth. | |
Age | The risk of blood cancer increases with age, particularly for leukaemia and lymphoma. | |
II. Environmental & Lifestyle | Radiation Exposure | High doses of radiation (e.g., nuclear radiation, repeated X-rays, radiation therapy) can damage blood cells and increase leukaemia risk. |
Chemical Exposure | Contact with industrial chemicals like benzene (found in gasoline, cigarette smoke and cleaning products) is linked to increased leukaemia risk. | |
III. Immune System Related | Autoimmune Disorders | Conditions like rheumatoid arthritis and lupus, which involve chronic inflammation, may increase the risk of lymphoma. |
Immunosuppression | Patients on long-term immunosuppressive drugs (e.g., after organ transplant) have a higher risk of developing lymphoma. |
Blood Cancer Types
The primary blood cancer types include:
- Leukaemia –It is a type of blood cancer that affects the blood and bone marrow. In this, the white blood cells are overproduced abnormally, which crowd out healthy blood cells. Leukaemia can be acute (fast-growing) or chronic (slow-growing) and is further classified based on the type of white blood cell affected (e.g., acute myeloid leukaemia, chronic lymphocytic leukaemia). It affects normal immune response.
- Lymphoma – This cancer affects the lymphatic system, which includes lymph nodes, the spleen, thymus, and bone marrow. Lymphocytes, a type of White blood cells, develop abnormally to cause lymphoma. Two types of lymphoma are:
- Hodgkin Lymphoma: Characterized by the presence of Reed-Sternberg cells (a specific type of abnormal cell).
- Non-Hodgkin Lymphoma: A diverse group of lymphomas that don't have Reed-Sternberg cells.
- Myeloma – This cancer affects plasma cells, which are a type of white blood cell in the bone marrow responsible for producing antibodies. In myeloma, abnormal plasma cells accumulate in the bone marrow and produce abnormal antibodies, leading to bone damage, kidney problems, and other complications.
Interesting facts about Blood Cancer
- According to estimates, more than 1.3 million new blood cancer cases are expected worldwide this year.
- Unlike many cancers, blood cancers don’t form solid tumours. Instead, they affect the blood, bone marrow, and lymphatic system.
- The five-year survival rate for leukaemia has increased from 14% in the 1960s to over 65% today due to medical advancements.
Symptoms of Blood Cancer
The symptoms of blood cancer vary depending on the type and stage of the cancer. Some common blood cancer symptoms include:
- Chronic fatigue
- Frequent infections
- Unexplained bruising or bleeding
- Swollen lymph nodes
- Weight loss
- Persistent fever or night sweats
How to Treat Blood Cancer: Cutting-Edge Approaches
What is a stem cell transplant?
Stem cell transplant, sometimes referred to as Bone Marrow Transplant, is a procedure that replaces damaged bone marrow with healthy stem cells. Stem cells are immature cells produced in the marrow of bones and can develop into any type of blood cell according to the body's needs. It can be classified into two types:
- Autologous Stem Cell Transplant – In this type, the patient’s stem cells are collected and stored before chemotherapy or radiation therapy to kill cancer cells. After the cancerous cells are eliminated, the healthy stem cells are infused back into the patient’s body to help rebuild bone marrow.
- Allogeneic Stem Cell Transplant – In this type, stem cells are obtained from a donor whose tissue type matches with the recipient. The donor’s stem cells are infused into the patient after their bone marrow has been destroyed by chemotherapy or radiation.
How Does Stem Cell Therapy Work?
- Conditioning – In this step, the patient undergoes a high-dose of chemotherapy treatment and sometimes radiation treatment to destroy cancer cells in the bone marrow. This process clears space for new stem cells and reduces the risk of the immune system rejecting the transplant.
- Transplantation – Healthy stem cells are introduced into the bloodstream through an IV fusion. These stem cells travel to the bone marrow and start the regeneration process.
- Engraftment and Recovery – The transplanted stem cells begin producing healthy blood cells, including red blood cells, white blood cells, and platelets.
What is immunotherapy?
The immune system is a collection of organs, special cells, and substances that protect the body from infections and diseases. Immune cells travel throughout the body to protect it from germs that cause infections. They also play a role in protecting the body from cancer in some ways.
Immunotherapy is an advanced treatment that uses the body’s immune system to fight cancer. Unlike traditional therapies, immunotherapy for blood cancer specifically targets cancerous cells without harming healthy ones.
Types of Immunotherapy for Blood Cancer
- Monoclonal Antibodies – Monoclonal antibody therapy is a targeted cancer treatment that mimics natural antibodies but is made in the laboratory. These mAbs work by directly killing cancer cells, activating the immune system to destroy them, blocking growth signals, or delivering chemotherapy/radiation directly to the tumour.
- Checkpoint Inhibitors – Cancer cells sometimes block immune cells, making them unable to recognise and attack cancer cells. Checkpoint inhibitors are MABs that release the brakes of the immune system and enable T cells to recognise and attack cancer cells. By blocking checkpoint proteins like CTLA-4, PD-1, or PD-L1, these inhibitors prevent cancer cells from suppressing the immune response.
- CAR-T Cell Therapy – In this therapy patient’s own T cells are genetically engineered to express a Chimeric Antigen Receptor (CAR) on their surface that helps them to recognise and kill cancer cells.
Comparing Stem Cell Therapy and Immunotherapy
Feature | Stem Cell Therapy | Immunotherapy |
Mechanism | Replaces diseased bone marrow | Strengthens the immune system to fight cancer |
Best for | Leukaemia, Lymphoma, Myeloma | Various blood cancers |
Common Side Effects | Short-term: Infection, bleeding, mucositis (inflammation of mouth/gut). - Long-term: Graft-versus-host disease (GVHD), organ damage, secondary cancers. | Immune-related adverse events (irAEs): Affecting skin, gut, liver, lungs, endocrine organs, etc. |
Conclusion
The advancements in blood cancer treatments are providing new hope for patients. As science progresses, the prospect of finding a complete cure for blood cancer becomes more promising. By integrating stem cell therapy and immunotherapy for cancer, medical experts are significantly improving survival rates and patient well-being. Staying informed and exploring these options is crucial for those affected by blood cancer and their families.